Overview

IO Vancomycin Spine

Status:
NOT_YET_RECRUITING
Trial end date:
2030-04-01
Target enrollment:
Participant gender:
Summary
The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.
Phase:
PHASE2
Details
Lead Sponsor:
The Methodist Hospital Research Institute